WebGet Rachel Humphrey's email address (r*****@berkeley.edu) and phone number (510642....) at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for 450M+ professionals. Try for free at rocketreach.co WebDr. Rachel W. Humphrey is Chief Medical Officer at Black Diamond Therapeutics. Dr. ... (BMS). Rachel also held multiple positions in global clinical development at Bayer. …
Rachel Humphrey email address & phone number AUTOPAY …
WebSep 29, 2024 · Previously, she held numerous senior leadership roles in cancer drug development, including Vice President, Head of Immuno-Oncology at Eli Lilly and Company, SVP and Head of Immuno-Oncology at AstraZeneca, Executive VP and Chief Medical Officer at Mirati Therapeutics, and VP, Clinical Development at Bristol-Myers Squibb (BMS). Dr. … WebJan 4, 2024 · Humphrey’s career is most notable for the supervision of the development of ipilimumab (Yervoy®) at BMS and sorafenib (Nexavar®) at Bayer. She received her B.A. from Harvard University, her M.D. from Case Western Reserve Medical School, and her training in internal medicine at The Johns Hopkins Hospital. black seed oil multiple sclerosis
About Us - Normunity
WebA marketing director, specialising in strategy, communication and innovation, with significant FMCG brand management experience at Mars, Nestle and Unilever. I'm a big picture thinker - marrying a commercial mindset with a talent for developing insightful and creative solutions to meet consumer and market needs. I've extensive leadership … WebSep 8, 2024 · Dr. Humphrey brings more than 20 years of experience as a leader in oncology drug developmentCAMBRIDGE, Mass. and NEW YORK, Sept. 08, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc ... WebSep 8, 2024 · CAMBRIDGE, Mass. and NEW YORK, Sept. 08, 2024 -- Black Diamond Therapeutics, Inc. , a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic... April 1, 2024 black seed oil muscle study